Skip to main content

Advertisement

Table 2 Relationship between FPR1 expression and clinicopathological features of ovarian cancer tissues

From: Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion

 FPR1 staining (%)FPR1 staining (intensity)
Neg ≤ 10Pos ≥ 80P-valuea012
EOC tissuesn.cases37 (100.0)11 (29.7)26 (70.3)0.39111 (29.7)17 (45.9)9 (24.3)
Age508 (21.6)1 (2.7)7 (18.9)0.081 (2.7)3 (10.8)4 (10.8)
> 5029 (78.4)10 (27.0)19 (51.4)0.1110 (27.0)14 (37.8)5 (13.5)
HistotypeLGSC3 (8.1)1 (2.7)2 (5.4)0.6121 (2.7)2 (5.4)0 (0.0)
HGSC28 (75.7)8 (21.6)20 (54.1)8 (21.6)13 (35.1)7 (18.9)
OCCC5 (13.5)1 (2.7)4 (10.8)1 (2.7)2 (5.4)2 (5.4)
mEOC1 (2.7)1 (2.7)0 (0.0)1 (2.7)0 (0.0)0 (0.0)
FIGOI6 (16.2)3 (8.1)3 (8.1)0.423 (8.1)2 (5.4)1 (2.7)
II9 (24.3)1 (2.7)8 (21.6)1 (2.7)4 (10.8)4 (10.8)
III21 (56.8)7 (18.9)14 (37.8)7 (18.9)10 (27.0)4 (10.8)
IV1 (2.7)0 (0.0)1 (2.7)0 (0.0)1 (2.7)0 (0.0)
  1. aP - value calculated using Pearson’s Chi-square (χ2) test